50
Participants
Start Date
September 30, 2012
Primary Completion Date
November 30, 2012
Study Completion Date
November 30, 2012
Angiographic run with new algorithm and low dose (50% dose)
Angiographic run with new algorithm and low dose (50% lower dose compared to Xper)
Angiographic run with predecessor algorithm and dose (100%)
Angiographic run with predecessor algorithm and dose (100% dose)
Radboud University Nijmegen Medical Center, Nijmegen
Philips Clinical & Medical Affairs Global
INDUSTRY